BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will make a presentation at the 2016 Canaccord Genuity Musculoskeletal Conference on Tuesday, March 1, 2016, at 9:00 a.m. ET. The conference is being held at the Hyatt Regency Hotel in Orlando, Florida.
